資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

頁面路徑選單

Production and Market of Chinese Microcrystalline cellulose Industry 2015-2020

  • LinkedIn
  • facebook
  • Twitter
出 版 商:AskCI
出版日期:2015/06/01
價  格:
USD 3,500 (Single-User License)
USD 3,700 (Hard copy)
線上訂購或諮詢
1. INTRODUCTION

In 2013, microcrystalline cellulose had produced over 20 thousand tons; and the microcrystalline cellulose market scale achieved 470 million in 2014. Microcrystalline cellulose, was wildly used in tanning, daily chemical products, medication, and food production, demands of microcrystalline cellulose is rising gradually; therefore, microcrystalline cellulose market will expand quickly. In foreseeable future, the demand of medical microcrystalline cellulose products grows 25% annually. ASKCI predicts Chinese domestic microcrystalline cellulose market cap will exceed 1.2 billion by the end of 2020.
3. MAIN CONTENT

Part Contents
Executive summary
Definition and methodology
I Microcrystalline cellulose industry operation
I-1 Production
I-2 Purchase
I-3 Sales
II Chinese microcrystalline cellulose industry 2014
II-1 Economic environment
II-1.2 Industry index
II-1.3 Foreign trade
II-2 Regulation
II-3 Technology
III Chinese microcrystalline cellulose market, 2013-2014
III-1 Domestic market supplement
III-1.1 MCC production, 2009-2014
III-1.2 Estimates production, 2015-2020
III-2 Domestic market demand
III-2.1 MCC demand, 2009-2014
III-2.2 Estimates demand, 2015-2020
III-3 Price index
IV Industry chain
IV-1 Upstream industries
IV-2 Downstream markets
IV-2.1 Pharmacy
IV-2.2 Food
IV-2.3 Cosmetics
V Import and export, 2012-2014
V-1 Chinese domestic imports
V-2 Chinese domestic exports
VI Major Companies and competitiveness
VI-1 Anhui Shunhere Pharmaceutical excipients Co., Ltd.
VI-1.1 Major products
VI-1.2 Sales
Vi-1.2 Distribution
VI-1.3 Competitive advantage
VI-2 Shandong Guangda Technological Development Co., Ltd.
VI-3 Qufu Tianli Modical Supplements Co., Ltd.
VI-4 Huzhou Zhanwang Pharmaceutical Co., Ltd.
VI-5 Yingkou AODA Pharmaceutical Co., Ltd.
VI-6 Huzhou City Linghu Xinwang Chemical Co., Ltd.
VI-7 Shandong Liaocheng a hua Pharmaceutical Co., Ltd.
VI-8 Yixing City Shendeli New Material Co., Ltd.
VI-9 Shandong Xinda Biotechnology Co., Ltd.
VII Forecasts, 2015-2020
VII-1 Development and trends
VII-2 Investment and risks
VII-3 Strategies
VIII Conclusion and recommendation
ASKCI’s legal disclaimer
回上頁